tiprankstipranks
Advertisement
Advertisement

TAK Stock Latest News

Takeda Targets Older Adults With New Dengue Vaccine Study, Eyeing Long-Term Market Upside
Company AnnouncementsTakeda Targets Older Adults With New Dengue Vaccine Study, Eyeing Long-Term Market Upside
4d ago
TAK
Takeda’s TAK-505 Trial Marks a New Bet on Difficult Solid Tumors
PremiumCompany Announcements
Takeda’s TAK-505 Trial Marks a New Bet on Difficult Solid Tumors
4d ago
TAK
Takeda Extends Pediatric Entyvio Data: What Long-Term Safety Tracking Means for TAK Investors
PremiumCompany Announcements
Takeda Extends Pediatric Entyvio Data: What Long-Term Safety Tracking Means for TAK Investors
11d ago
TAK
Takeda’s Real-World Dengue Vaccine Study Could Reshape Its Emerging Markets Outlook
PremiumCompany Announcements
Takeda’s Real-World Dengue Vaccine Study Could Reshape Its Emerging Markets Outlook
11d ago
TAK
Spyre Therapeutics price target raised to $80 from $65 at Wedbush
PremiumThe Fly
Spyre Therapeutics price target raised to $80 from $65 at Wedbush
14d ago
TAK
SYRE
Takeda Updates Early-Stage Multiple Myeloma Study for TAK-079, Signaling Ongoing Oncology Push
PremiumCompany AnnouncementsTakeda Updates Early-Stage Multiple Myeloma Study for TAK-079, Signaling Ongoing Oncology Push
17d ago
TAK
Takeda upgraded to Outperform from Market Perform at Bernstein
Premium
The Fly
Takeda upgraded to Outperform from Market Perform at Bernstein
19d ago
TAK
Denali Therapeutics regains full rights to DNL593
Premium
The Fly
Denali Therapeutics regains full rights to DNL593
22d ago
TAK
DNLI
Abivax appoints Michael Nesrallah as chief commercial officer
PremiumThe Fly
Abivax appoints Michael Nesrallah as chief commercial officer
26d ago
TAK
ABVX
Axsome Therapeutics enters TAK-063 asset purchase agreement with Takeda
PremiumThe Fly
Axsome Therapeutics enters TAK-063 asset purchase agreement with Takeda
26d ago
TAK
AXSM
Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
PremiumThe Fly
Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
28d ago
JNJ
TAK
Alumis price target raised to $55 from $50 at Oppenheimer
PremiumThe Fly
Alumis price target raised to $55 from $50 at Oppenheimer
28d ago
JNJ
TAK
Takeda announces new data from Phase 3 studies of TAK-279
PremiumThe FlyTakeda announces new data from Phase 3 studies of TAK-279
29d ago
TAK
Alkermes price target lowered to $43 from $45 at Piper Sandler
Premium
The Fly
Alkermes price target lowered to $43 from $45 at Piper Sandler
1M ago
TAK
ALKS
Takeda’s Long-Term Psoriatic Arthritis Trial Could Reshape TAK’s Immunology Outlook
Premium
Company Announcements
Takeda’s Long-Term Psoriatic Arthritis Trial Could Reshape TAK’s Immunology Outlook
1M ago
TAK
Takeda Advances Dual-Therapy Ulcerative Colitis Study, Keeping Entyvio in the GI Spotlight
PremiumCompany Announcements
Takeda Advances Dual-Therapy Ulcerative Colitis Study, Keeping Entyvio in the GI Spotlight
1M ago
TAK
Takeda’s Dual-Drug Crohn’s Study Could Reframe Entyvio’s Role in IBD Portfolios
PremiumCompany Announcements
Takeda’s Dual-Drug Crohn’s Study Could Reframe Entyvio’s Role in IBD Portfolios
1M ago
TAK
Takeda Tracks Real-World Safety of Alunbrig in Japanese Lung Cancer Patients
PremiumCompany Announcements
Takeda Tracks Real-World Safety of Alunbrig in Japanese Lung Cancer Patients
1M ago
TAK
Takeda’s New South Korea HAE Study Aims to Cement Takhzyro’s Real World Edge
PremiumCompany Announcements
Takeda’s New South Korea HAE Study Aims to Cement Takhzyro’s Real World Edge
2M ago
TAK
Takeda’s EXPLORHAE HAE Study in Egypt: Real‑World Data With Long‑Term Investor Upside
PremiumCompany AnnouncementsTakeda’s EXPLORHAE HAE Study in Egypt: Real‑World Data With Long‑Term Investor Upside
2M ago
TAK
Takeda Deepens Real-World Evidence in Ultra-Rare cTTP With New ADAMTS13 Study
Premium
Company Announcements
Takeda Deepens Real-World Evidence in Ultra-Rare cTTP With New ADAMTS13 Study
2M ago
TAK
Takeda-Backed Phase 3 Lung Cancer Trial Pits Novel IBI363 Against Docetaxel
Premium
Company Announcements
Takeda-Backed Phase 3 Lung Cancer Trial Pits Novel IBI363 Against Docetaxel
2M ago
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >